Paracetamol Use During Pregnancy: What This New Research Really Shows
Article: D'Antonio F et al. "Prenatal paracetamol exposure and child neurodevelopment: a systematic review and meta-analysis." The Lancet Obstetrics & Gynaecology, Published online January 16, 2026.
https://doi.org/10.1016/S3050-5038(25)00211-0
Executive Summary (The Elevator Pitch)
This rigorous analysis of over 40 studies involving millions of births found that taking paracetamol (Tylenol/acetaminophen) during pregnancy—when used as directed—does not increase the risk of autism, ADHD, or intellectual disability in children. The findings directly contradict recent political claims and support existing medical guidance that paracetamol remains the safest pain and fever medication for pregnant people. Importantly, avoiding paracetamol could actually be more dangerous, since untreated fever and pain during pregnancy can cause miscarriage, birth defects, and preterm birth.
Who Did This Research?
Lead Authors:
- Francesco D'Antonio, PhD (University of Chieti, Italy)
- Maria Elena Flacco, PhD (University of Ferrara, Italy)
- Prof Asma Khalil, FRCOG (St George's University Hospitals NHS Foundation Trust & University of Liverpool, UK)
Collaborating Institutions:
- Universities in Italy (Chieti, Ferrara, Bologna)
- UK hospitals and universities (Liverpool, London)
- Karolinska Institutet, Sweden
- University of Oslo, Norway
Conflicts of Interest:
- None declared – No funding received, no financial ties to pharmaceutical companies
- Study conducted independently by academic researchers
What They Actually Did
The Big Picture:
- Analyzed 43 published studies examining whether paracetamol use during pregnancy causes neurodevelopmental problems in kids
- Focused specifically on three outcomes: autism spectrum disorder, ADHD, and intellectual disability
- Combined data from 17 high-quality studies in their main statistical analysis
- Looked at data from hundreds of thousands to millions of births (sample sizes varied by analysis)
The Gold Standard Approach:
- Prioritized "sibling comparison studies" – these compare children within the same family where the mother took paracetamol in one pregnancy but not another
- This design cleverly controls for genetics, family environment, parenting style, and socioeconomic factors that could confuse the results
- Used a validated quality assessment tool (QUIPS) to separate strong studies from weak ones
Key Findings (What the Data Actually Shows)
Main Results from Sibling Comparison Studies:
- Autism: No increased risk (odds ratio 0.98, meaning essentially identical risk whether exposed or not)
- ADHD: No increased risk (odds ratio 0.95)
- Intellectual Disability: No increased risk (odds ratio 0.93)
Translation: An odds ratio of 1.0 means no difference. All these results are extremely close to 1.0 and statistically non-significant, meaning paracetamol exposure made no meaningful difference.
Consistency Checks:
- Results remained the same when looking only at the highest-quality studies
- Results remained the same when looking only at studies with 5+ years of follow-up
- Results remained the same across different types of statistical analyses
Strengths (Why This Research Is Trustworthy)
Methodological Rigor:
- Used sibling comparison design, which is considered the strongest observational approach for minimizing confounding (when other factors muddy the waters)
- Applied systematic quality assessment using the QUIPS tool, not just accepting all studies equally
Scale and Comprehensiveness:
- Massive sample sizes – the Swedish cohort alone included 2.48 million births
- Comprehensive search across multiple major medical databases through late 2025
Transparency:
- Pre-registered their analysis plan (prevents cherry-picking results)
- Clearly reported all analyses including sensitivity checks
- Acknowledged limitations openly
Clinical Relevance:
- Findings align with guidance from major medical organizations (American College of Obstetricians and Gynecologists, Royal College of Obstetricians and Gynaecologists)
- Addresses a real-world concern that affects millions of pregnant people annually
Biological Plausibility:
- Earlier observational studies showed associations, but this review demonstrates those were likely due to confounding factors (the underlying illness requiring paracetamol, not the drug itself)
Weaknesses (What Could Be Better)
Measurement Challenges:
- Many studies relied on mothers self-reporting paracetamol use, sometimes years after pregnancy, which introduces recall bias (people may misremember)
- Exposure definitions varied widely – some studies asked about any use, others about duration or frequency, making direct comparisons difficult
Outcome Assessment Variability:
- Diagnostic criteria for autism, ADHD, and intellectual disability have evolved significantly over time and across countries
- Some studies used validated clinical diagnoses while others used screening questionnaires, which aren't equivalent
Confounding by Indication Problem:
- The "elephant in the room" – people take paracetamol because they're sick, in pain, or have fever; these underlying conditions might independently affect neurodevelopment
- While sibling studies help address this, they don't completely eliminate it if conditions vary between pregnancies
Limited Dose-Response Data:
- Few studies reported whether risk (if any) changes with different doses, durations, or timing during pregnancy
- This makes it hard to give specific guidance like "X days is safe but Y days isn't"
Statistical Power Issues:
- For subgroup analyses (like effects by trimester or sex of baby), there wasn't enough data to draw firm conclusions
- Small number of sibling comparison studies means these findings, while strong, come from limited sources
Publication Bias Unknown:
- With fewer than 10 studies in each meta-analysis, the authors couldn't formally test whether negative studies were less likely to be published
- Studies showing "no effect" are notoriously harder to publish than those showing dramatic findings
What This Means at the Dinner Table
The Bottom Line:
The best available evidence shows paracetamol is safe when used appropriately during pregnancy. Earlier concerns appear to have been due to confounding factors – essentially, sick pregnant people who need medication have different baseline risks than healthy ones, and it's the underlying illness (especially fever) that poses risks, not the medication.
Why This Matters:
Paracetamol is one of the few pain/fever medications considered safe in pregnancy. Alternatives like ibuprofen can cause serious fetal complications, and opioids carry addiction risks. Untreated fever during pregnancy can cause miscarriage and birth defects. Creating fear around paracetamol could lead pregnant people to suffer unnecessarily or turn to more dangerous alternatives.
The Controversy Context:
In September 2025, political figures suggested paracetamol might cause autism, citing weaker evidence. This study directly addresses those claims with more rigorous methodology and finds no credible link. This is a good example of why medical decisions should be based on best available evidence, not political statements.